ArticleJournal of experimental & clinical cancer research : CR2024

Inhibition of choline metabolism in an angioimmunoblastic T-cell lymphoma preclinical model reveals a new metabolic vulnerability as possible target for treatment.

Adrien Krug et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.